Chemoprevention of colorectal tumors: Role of lactulose and of other agents

Scandinavian Journal of Gastroenterology, Supplement

Volumn 32, Issue 222, 1997, Pages 72-75

  De Leon, M Ponz ^a,b   Roncucci, L ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

adenoma; cancer; chemoprevention; colon; lactulose; N acetylcysteine; polyps; rectum; tumor; vitamins

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; LACTULOSE; RETINOL; VITAMIN B GROUP; ASCORBIC ACID; GASTROINTESTINAL AGENT;

ADENOMA; COLORECTAL CANCER; HUMAN; PRIORITY JOURNAL; SHORT SURVEY; ADENOMATOUS POLYP; ARTICLE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COLORECTAL TUMOR; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; RANDOMIZED CONTROLLED TRIAL; TUMOR RECURRENCE;

ACETYLCYSTEINE; ADENOMATOUS POLYPS; ASCORBIC ACID; CHEMOPREVENTION; COLORECTAL NEOPLASMS; GASTROINTESTINAL AGENTS; HUMANS; LACTULOSE; NEOPLASM RECURRENCE, LOCAL; VITAMIN A; VITAMIN E;

EID: 34547648744     PISSN: 00855928     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365521.1997.11720724     Document Type: Short Survey

References (18)

1. Miller AB, Berrino F, Hill M, Pietinen P, Riboli E, Wahrendorf J. Diet in aetiology of cancer: a review. Eur J Cancer 1994;30A:207-20.
2. Greenwald P, Nixon DW, Malone WF, Kelloff GJ, Stern HR, Witkin KM. Concepts in cancer chemoprevention research. Cancer 1990;65:1483-90.
3. Bertram JS, Kolonel LN, Meyskens FL. Rationale and strategies for chemoprevention of cancer in humans. Cancer Res 1987; 47:3012-31.
4. Wattenberg LW. Chemoprevention of cancer. Cancer Res 1985; 45:1-8.
5. Ellenberg SS. Surrogate endpoints. Br J Cancer 1993;68:457-9.
6. Jass JR. Colorectal adenoma progression and genetic change: is there a link? Ann Med 1995;27:301-6.
7. Haggitt RC, Reid BJ. Hereditary gastrointestinal polyposis syndromes. Am J Surg Pathol 1986;10(12):871-87.
8. Mecklin JP, Ponz de Leon M. Epidemiology of HNPCC. Anticancer Res 1994;14:1625-30.
9. Roncucci L, Medline A, Bruce R. Classification of aberrant crypt foci and microadenomas in human colon. Cancer Epidemiol Biomed Prev 1991;1:57-60.
10. 3H-thymidine labeling index: cell proliferation of colorectal carcinoma in three different centers. Modern Pathol 1991;4:627-31.
11. Thune I, Lund E. Physical activity and risk of colorectal cancer in men and women. Br J Cancer 1996;73:1134-40.
12. Church JM. Complete colonscopy: how often? And if not, why not? Am J Gatroenterol 1994;89:556-60.
13. Roncucci L, Di Donato P, Carati L, Ferrari A, Perini M, Bertoni G, et al. Antioxidant vitamins or lactulose for the prevention of the recurrence of colorectal adenomas. Dis Colon Rectum 1993;36:227-34.
14. Greenberg ER, Baron JA, Tosteson TD, Freeman DH, Beck GJ, Bond JH, et al. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. N Engl J Med 1994;331:141-7.
15. Kowalski TE, Falestiny M, Furth E, Malet PF. Vitamin A hepatotoxicity: a cautionary note regarding 25,000 IU supplements. Am J Med 1994;97:523-8.
16. Lippman SM, Benner SE, Ki Hong W. Cancer chemoprevention. J Clin Oncol 1994;12:851-73.
17. De Vries N, Pastorino U, Van Zandwijk. Chemoprevention of second primary tumours in head and neck cancer in Europe: EUROSCAN. Eur J Cancer 1994;30B:367-8.
18. Izzotti A, Camoirano A, D'Agostini F, Sciacca S, De Naro Papa F, Cesarone CF, et al. Biomarker alterations produced in rat lung by intratracheal instillations of air particulate extracts and chemoprevention with oral N-acetylcysteine. Cancer Res 1996;56:1533-8.